中胤時尚(300901.SZ)與北京服裝學院簽署產學研合作框架協議
格隆匯7月29日丨中胤時尚(300901.SZ)公佈,公司於2021年7月29日與北京服裝學院簽署了《產學研合作框架協議》,雙方充分發揮各自優勢和資源,共同推進校企合作,實現雙方的資源共享和合作共贏。該次簽署的框架合作協議合作經費每年200萬元,有效期5年,無需提交公司董事會、股東大會審議。
北京服裝學院為一所特色鮮明、國內一流、國際知名的時尚類高等學校,在服飾時尚、藝術設計、造型藝術等方面有豐富教學資源和強大的研發能力。公司與北京服裝學院建立戰略合作關係,能夠進一步發揮公司的產業優勢和北京服裝學院的教學、科研優勢,實現雙方在人才培養、產學研融合及發佈推廣等方面的合作共贏。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.